Imran Mahmud

GCMS profiling of bioactive phytocompounds from Curculigo orchiodes Gaertn. root extract and evaluation of antioxidant, and antidiabetic activities: A computational drug development approach (2025)

PLoS ONE

Mahmud, Imran; Saifullah, Md. Khalid; Morshed, Md. Niaj; Hossain, Md. Arju; Shahria, Naznin; Barman, Apurba Kumar; Ahmed, Famim; Islam, Md. Jakaria; Khan, Toufiq Ejaj; Biswas, Nripendra Nath

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Designing nanoparticle-based bioaffinity assays for the detection of extracellular vesicles (2025)

Nanomedicine

Islam, Md. Khirul; Mahmud, Imran; Leivo, Janne

(B1 Vertaisarvioitu muu artikkeli (esim. pääkirjoitus, letter, comment) tieteellisessä lehdessä)

High‐Sensitivity Detection of Urinary Extracellular Vesicles With Upconverting Nanoparticle‐Based Lateral Flow Immunoassay (2025)

Journal of Extracellular Biology

Islam, Md. Khirul; Mahmud, Imran; Ali, Klinton; Salminen, Teppo; Taimen, Pekka; Boström, Peter J.; Leivo, Janne; Lamminmäki, Urpo; Martiskainen, Iida

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Experimental Validation of Antiobesogenic and Osteoprotective Efficacy of Ginsenoside CK via Targeting Lipid and Atherosclerosis Pathways (2025)

Life

Morshed, Md. Niaj; Akter, Reshmi; Mahmud, Imran; Gwon, Ah-Yeong; Jeang, Jin Woo; Lee, Yeong-Geun; Park, Dae Won; Yang, Deok Chun; Kim, Yeon Ju; Kang, Se-Chan

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Imran

Mahmud

Contact

Publications

Sort by:

GCMS profiling of bioactive phytocompounds from Curculigo orchiodes Gaertn. root extract and evaluation of antioxidant, and antidiabetic activities: A computational drug development approach (2025)

Designing nanoparticle-based bioaffinity assays for the detection of extracellular vesicles (2025)

High‐Sensitivity Detection of Urinary Extracellular Vesicles With Upconverting Nanoparticle‐Based Lateral Flow Immunoassay (2025)

Experimental Validation of Antiobesogenic and Osteoprotective Efficacy of Ginsenoside CK via Targeting Lipid and Atherosclerosis Pathways (2025)